Evogene Ltd. Logo

Evogene Ltd.

AI-powered platform designing life-science solutions for health, ag, and industrial sectors.

EVGN | TA

Overview

Corporate Details

ISIN(s):
IL0011050551
LEI:
Country:
Israel
Address:
13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Evogene Ltd. is a computational biology company that aims to revolutionize the discovery and development of life-science products. At its core is the proprietary Computational Predictive Biology (CPB) platform, which leverages big data and advanced artificial intelligence to design novel solutions based on microbes, small molecules, and genetic elements. The platform's tech-engines are designed to increase the probability of success while reducing development time and costs. Evogene's solutions cater to the human health, agriculture, and industrial sectors. The company operates through a group structure, licensing its technology to subsidiary companies that focus on specific commercial applications, thereby driving innovation across multiple life-science markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-30 16:15
Registration Form
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1
English 551.8 KB
2025-09-30 16:15
Foreign Filer Report
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1
English 36.4 KB
2025-09-30 16:00
Foreign Filer Report
Results of Operations- Six Months Ended June 30, 2025
English 372.7 KB
2025-09-30 16:00
Foreign Filer Report
Results of Operations- Six Months Ended June 30, 2025
English 36.5 KB
2025-09-10 16:00
Foreign Filer Report
Evogene Investor Presentation
English 1.8 MB
2025-09-10 16:00
Foreign Filer Report
Evogene Investor Presentation
English 36.5 KB
2025-08-28 16:00
Report Publication Announcement
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference …
English 110.4 KB
2025-08-28 16:00
Foreign Filer Report
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference …
English 36.6 KB
2025-08-19 16:00
Foreign Filer Report
Reports Second Quarter 2025 Financial Results
English 2.2 MB
2025-08-19 16:00
Foreign Filer Report
Reports Second Quarter 2025 Financial Results
English 36.7 KB
2025-08-19 01:00
Foreign Filer Report
Other Report or Announcement
English 122.5 KB
2025-08-12 16:00
Regulatory News Service
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 135.0 KB
2025-08-12 16:00
Foreign Filer Report
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 36.6 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 63.2 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 36.5 KB

Automate Your Workflow. Get a real-time feed of all Evogene Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Evogene Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Evogene Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.